Bulltick Wealth Management, LLC Vertex Pharmaceuticals Inc Transaction History

Bulltick Wealth Management, LLC

$423 Billion
Q3 2025

A detailed history of Bulltick Wealth Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Bulltick Wealth Management, LLC holds 9,102 shares of VRTX stock, worth $3.95 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares

9,102

Previous 9,095 0.08%

Holding current value

$3.95 Million

Previous $4.05 Billion 11.96%

% of portfolio

0.84%

Previous 1.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$366.54 - $479.53 $2,565 - $3,356	7 Added 0.08%	9,102 $3.56 Billion
Q2 2025 Aug 11, 2025	BUY	$421.16 - $509.5 $2,526 - $3,057	6 Added 0.07%	9,095 $4.05 Billion
Q1 2025 May 12, 2025	BUY	$402.49 - $513.76 $6,842 - $8,733	17 Added 0.19%	9,089 $4.41 Billion
Q3 2024 Nov 14, 2024	SELL	$460.0 - $505.78 $4.7 Million - $5.16 Million	-10,210 Reduced 52.95%	9,072 $4.22 Billion
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $256,844 - $281,030	-630 Reduced 3.16%	19,282 $8.06 Billion

Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $6.83 Million - $8.18 Million	19,912 New	19,912 $8.1 Billion
Q3 2023 Apr 24, 2024	SELL	$338.18 - $362.46 $314,507 - $337,087	-930 Reduced 4.34%	20,477 $7.12 Billion
Q2 2023 Apr 24, 2024	SELL	$314.42 - $351.91 $44,018 - $49,267	-140 Reduced 0.65%	21,407 $7.53 Billion
Q1 2023 Apr 24, 2024	SELL	$283.23 - $323.1 $2.18 Million - $2.48 Million	-7,689 Reduced 26.3%	21,547 $6.79 Billion
Q4 2022 Apr 24, 2024	SELL	$285.76 - $321.48 $1.59 Million - $1.79 Million	-5,555 Reduced 15.97%	29,236 $8.44 Billion
Q3 2022 Apr 24, 2024	SELL	$273.83 - $305.53 $1,916 - $2,138	-7 Reduced 0.02%	34,791 $10.1 Billion
Q1 2022 Apr 24, 2024	SELL	$221.42 - $260.97 $1.19 Million - $1.4 Million	-5,374 Reduced 13.38%	34,798 $9.08 Billion
Q4 2021 Apr 24, 2024	SELL	$177.01 - $223.45 $379,863 - $479,523	-2,146 Reduced 5.07%	40,172 $8.82 Billion
Q3 2021 Apr 24, 2024	SELL	$181.39 - $202.99 $285,689 - $319,709	-1,575 Reduced 3.59%	42,318 $7.68 Billion
Q2 2021 Apr 24, 2024	BUY	$187.49 - $221.1 $7.86 Million - $9.27 Million	41,906 Added 2109.01%	43,893 $8.85 Billion
Q1 2021 Apr 24, 2024	BUY	$207.02 - $241.31 $150,710 - $175,673	728 Added 57.82%	1,987 $427 Million
Q4 2020 Apr 24, 2024	SELL	$207.01 - $276.09 $3.86 Million - $5.15 Million	-18,653 Reduced 93.68%	1,259 $298 Million

Others Institutions Holding VRTX

# of Institutions

1,787

Shares Held

231M

Call Options Held

1.83M

Put Options Held

1.21M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $111B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bulltick Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bulltick Wealth Management, LLC with notifications on news.

Account

Bulltick Wealth Management, LLC Vertex Pharmaceuticals Inc Transaction History